Literature DB >> 14645580

Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells.

Mingfang Tao1, Michael Kruhlak, Shuhua Xia, Elliot Androphy, Zhi-Ming Zheng.   

Abstract

Human papillomavirus (HPV) type 16 E6 (16E6) is an oncogenic, multifunctional nuclear protein that induces p53 degradation and perturbs normal cell cycle control, leading to immortalization and transformation of infected keratinocytes and epithelial cells. Although it is unclear how 16E6 disrupts the epigenetic profile of host genes, its presence in the nucleus is a key feature. The present report describes intrinsic properties of 16E6 that influence its nuclear import in living cells. When the coding region of full-length 16E6 was inserted in frame into the C terminus of green fluorescent protein (GFP), it effectively prevented the 16E6 pre-mRNA from being spliced and led to the expression of a GFP-E6 fusion which localized predominantly to the nucleus. Further studies identified three novel nuclear localization signals (NLSs) in 16E6 that drive the protein to accumulate in the nucleus. We found that all three NLS sequences are rich in positively charged basic residues and that point mutations in these key residues could abolish the retention of 16E6 in the nucleus as well as the p53 degradation and cell immortalization activities of the protein. When inserted into corresponding regions of low-risk HPV type 6 E6, the three NLS sequences described for 16E6 functioned actively in converting the normally cytoplasmic HPV type 6 E6 into a nuclear protein. The separate NLS sequences, however, appear to play different roles in nuclear import and retention of HPV E6. The discovery of three unique NLS sequences in 16E6 provides new insights into the nuclear association of 16E6 which may reveal other novel activities of this important oncogenic protein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645580      PMCID: PMC296047          DOI: 10.1128/jvi.77.24.13232-13247.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  76 in total

1.  MaRX: an approach to genetics in mammalian cells.

Authors:  G J Hannon; P Sun; A Carnero; L Y Xie; R Maestro; D S Conklin; D Beach
Journal:  Science       Date:  1999-02-19       Impact factor: 47.728

2.  Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130.

Authors:  K Smith-McCune; D Kalman; C Robbins; S Shivakumar; L Yuschenkoff; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

3.  The importin beta/importin 7 heterodimer is a functional nuclear import receptor for histone H1.

Authors:  S Jäkel; W Albig; U Kutay; F R Bischoff; K Schwamborn; D Doenecke; D Görlich
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

4.  Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells.

Authors:  Y Liu; J J Chen; Q Gao; S Dalal; Y Hong; C P Mansur; V Band; E J Androphy
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300.

Authors:  H Zimmermann; R Degenkolbe; H U Bernard; M J O'Connor
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements.

Authors:  V Band; D Zajchowski; V Kulesa; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

7.  Evidence for distinct substrate specificities of importin alpha family members in nuclear protein import.

Authors:  M Köhler; C Speck; M Christiansen; F R Bischoff; S Prehn; H Haller; D Görlich; E Hartmann
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

8.  Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein.

Authors:  W Beerheide; H U Bernard; Y J Tan; A Ganesan; W G Rice; A E Ting
Journal:  J Natl Cancer Inst       Date:  1999-07-21       Impact factor: 13.506

9.  The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.

Authors:  D Patel; S M Huang; L A Baglia; D J McCance
Journal:  EMBO J       Date:  1999-09-15       Impact factor: 11.598

10.  HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.

Authors:  P Hawley-Nelson; K H Vousden; N L Hubbert; D R Lowy; J T Schiller
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  30 in total

1.  HPV E6 proteins target Ubc9, the SUMO conjugating enzyme.

Authors:  Phillip R Heaton; Adeline F Deyrieux; Xue-Lin Bian; Van G Wilson
Journal:  Virus Res       Date:  2011-04-12       Impact factor: 3.303

Review 2.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

3.  p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes.

Authors:  Thibault Mesplède; David Gagnon; Fanny Bergeron-Labrecque; Ibrahim Azar; Hélène Sénéchal; François Coutlée; Jacques Archambault
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

4.  Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells.

Authors:  S Tang; M Tao; J P McCoy; Z M Zheng
Journal:  Oncogene       Date:  2006-03-30       Impact factor: 9.867

5.  Inhibition of Human Adenovirus Replication by the Importin α/β1 Nuclear Import Inhibitor Ivermectin.

Authors:  Cason R King; Tanner M Tessier; Mackenzie J Dodge; Jason B Weinberg; Joe S Mymryk
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

6.  Low risk HPV-6E6 induces apoptosis in bone marrow-derived dendritic cells.

Authors:  Lina Sun; Lei Zhao; Dan Li; Shuai Xu; Xuexin Hou; Zhenjun Li
Journal:  Oncol Lett       Date:  2017-11-15       Impact factor: 2.967

7.  Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites.

Authors:  Sohrab Bodaghi; Rong Jia; Zhi-Ming Zheng
Journal:  Virology       Date:  2009-02-01       Impact factor: 3.616

Review 8.  Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.

Authors:  Zhi-Ming Zheng
Journal:  Int J Biol Sci       Date:  2010-12-01       Impact factor: 6.580

9.  Identification and functional analysis of NOL7 nuclear and nucleolar localization signals.

Authors:  Guolin Zhou; Colleen L Doçi; Mark W Lingen
Journal:  BMC Cell Biol       Date:  2010-09-27       Impact factor: 4.241

10.  The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein.

Authors:  David Pim; Vjekoslav Tomaic; Lawrence Banks
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.